StockTipsArenaBeta

BUY Ajanta Pharma Limited — Pradip Hotchandani, Prudent Corporate Advisory Services

BUYAjanta Pharma Limited

byPradip Hotchandani, Prudent Corporate Advisory ServicesHorizon: Swing (≤2wk)11 Aug 2026via CNBC Awaaz.

Entry₹3,538Inferred
Target₹3,700
Total upside +4.58% (call closed)
Stop loss₹3,480-1.64% risk
Exit₹3,70017 Aug 2026, 9:25 am
Target hit+4.58%0.00%upside left
Follow Pradip Hotchandani for new calls(22% target hit, 37 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 1 active Swing call on AJANTPHARMSee 265 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Aug 2026
6 supporting1 neutral3 opposing
Supports the BUY call (6)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·17 Aug · today

Ajanta Pharma Shares Rise 2% as Q1 Profit Reaches Rs 334 Crore

NewsGoogle News·14 Aug · 2d ago

(opens in new tab)

Q1 Results Today Highlights: Swiggy narrows loss, Bajaj Finance, M&M, Gillette, Vedanta, Vedanta Aluminium, Ajanta Pharma, IRFC, ICRA, Niva Bupa profit rise, Hyundai PAT down; Torrent Pharma PAT up 3.3%; Tata Steel profit jumps 19%, NSDL's PAT up 9%

NewsHbl·30 Jul · 2w ago

(opens in new tab)

Dividend Alert: Ajanta Pharma Announces Interim Dividend — Check Record Date, Payout Date

NewsNdtv-Profit·30 Jul · 2w ago

(opens in new tab)

Ajanta Pharma Q1 profit jumps 31% on strong US sales; declares ₹32 dividend

NewsCnbc-Tv18·30 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (1)

Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·30 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (3)

Ajanta Pharma Share: डिविडेंड रिकॉर्ड डेट पर **3%** गिरा शेयर, जानिए क्या है वजह

NewsGoogle News·5 Aug · 2w ago

(opens in new tab)

Ajanta Pharma Share Price: डिव्हिडंडमुळे शेअर पडला 3%, पण ही आहे खरी बातमी!

NewsGoogle News·5 Aug · 2w ago

(opens in new tab)

Ajanta Pharma షేర్ ధర పడిపోయింది.. కారణం ఇదే!

NewsGoogle News·5 Aug · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.